Evidence map›Paper›PMID 34838409›Full record

ArticleFood chemistry2022

Inhibition of the SARS-CoV-2 3CL

Miha Bahun, Marko Jukić, Domen Oblak, Luka Kranjc, Gregor Bajc, Matej Butala, Krištof Bozovičar, Tomaž Bratkovič, Črtomir Podlipnik, Nataša Poklar Ulrih

Open access · hybridAbstract read
In one paragraph

Article in Food chemistry, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 57 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
57citing papers in PubMed, 1 pooled it
14.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

57 citing papers in PubMed, 1 synthesis or guideline pooled it, 114 citations in OpenAlex.

  1. The Antiviral Potential ofMolecules (Basel, Switzerland) · 2024
    Pooled it
  2. Exploring novel isatin derivatives as SARS-CoV-2 3CLJournal of enzyme inhibition and medicinal chemistry · 2026
    Article
  3. Integrated Evaluation ofPharmaceuticals (Basel, Switzerland) · 2026
    Article
  4. Review
  5. Uncovering the covalent inhibitors of SARS-CoV-2 MJournal of pharmaceutical analysis · 2026
    Article
  6. Review
  7. Article
  8. The Antiviral Activity of Polyphenols.Molecular nutrition & food research · 2025
    Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Computational andFrontiers in pharmacology · 2025
    Article
  14. Article
  15. Article
  16. Article
  17. In vitro study on efficacy of SKF7BMC complementary medicine and therapies · 2024
    Article
  18. Review
  19. Review
  20. Utilizing sinapic acid as an inhibitory antiviral agent against MERS-CoV PLpro.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Miha BahunDepartment of Food Science and Technology, Biotechnical Faculty, University of Ljubljana, SI-1000 Ljubljana, Slovenia.
Marko JukićLaboratory of Physical Chemistry and Chemical Thermodynamics, Faculty of Chemistry and Chemical Engineering, University of Maribor, SI-2000 Maribor, Slovenia; Faculty of Mathematics, Natural Sciences and Information Technologies, University of Primorska, SI-6000 Koper, Slovenia.
Domen OblakDepartment of Chemistry and Biochemistry, Faculty of Chemistry and Chemical Technology, University of Ljubljana, SI-1000 Ljubljana, Slovenia.
Luka KranjcDepartment of Food Science and Technology, Biotechnical Faculty, University of Ljubljana, SI-1000 Ljubljana, Slovenia.
Gregor BajcDepartment of Biology, Biotechnical Faculty, University of Ljubljana, SI-1000 Ljubljana, Slovenia.
Matej ButalaDepartment of Biology, Biotechnical Faculty, University of Ljubljana, SI-1000 Ljubljana, Slovenia.
Krištof BozovičarDepartment of Pharmaceutical Biology, Faculty of Pharmacy, University of Ljubljana, SI-1000 Ljubljana, Slovenia.
Tomaž BratkovičDepartment of Pharmaceutical Biology, Faculty of Pharmacy, University of Ljubljana, SI-1000 Ljubljana, Slovenia.
Črtomir PodlipnikDepartment of Chemistry and Biochemistry, Faculty of Chemistry and Chemical Technology, University of Ljubljana, SI-1000 Ljubljana, Slovenia. Electronic address: crtomir.podlipnik@fkkt.uni-lj.si.
Nataša Poklar UlrihDepartment of Food Science and Technology, Biotechnical Faculty, University of Ljubljana, SI-1000 Ljubljana, Slovenia; Centre of Excellence for Integrated Approaches in Chemistry and Biology of Proteins (CIPKeBiP), SI-1000 Ljubljana, Slovenia. Electronic address: natasa.poklar@bf.uni-lj.si.
University of Ljubljana · SICentre of Excellence for Integrated Approaches in Chemistry and Biology of Proteins · SIUniversity of Maribor · SI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The abundance of polyphenols in edible plants makes them an important component of human nutrition. Considering the ongoing COVID-19 pandemic, a number of studies have investigated polyphenols as bioactive constituents. We applied in-silico molecular docking as well as molecular dynamics supported by in-vitro assays to determine the inhibitory potential of various plant polyphenols against an important SARS-CoV-2 therapeutic target, the protease 3CL

Indexed as

PolyphenolsCoronavirus 3C ProteasesMolecular Docking SimulationPeptide HydrolasesSARS-CoV-23C-like proteinase, SARS-CoV-2Coronavirus 3C ProteasesPeptide HydrolasesPolyphenols3CL(pro)4-hydroxy-3-nitrophenylacetic acid (PubChem CID: 447364)caffeic acid (PubChem CID: 689043)chlorogenic acid (PubChem CID: 1794427)COVID-19curcumin (PubChem CID: 969516)Edible plantsellagic acid (PubChem CID: 5281855)epigallocatechin gallate (PubChem CID: 65064)ferulic acid (PubChem CID: 445858)galangin (PubChem CID: 5281616)isorhamnetin (PubChem CID: 5281654)kaempferol (PubChem CID: 5280863)kaempferol-rutinoside (PubChem CID:5318767)phlorizin (PubChem CID: 6072)PolyphenolsProtease inhibitorprotocatechuic acid (PubChem CID: 72)quercetin (PubChem CID: 5280343)quinic acid (PubChem CID: 6508)resveratrol (PubChem CID: 445154)SARS-CoV-2sinapic acid (PubChem CID: 637775)syringic acid (PubChem CID: 10742)umbellic acid (PubChem CID: 446611)

Identifiers

PMID34838409
PMCPMC8592230
OpenAlexW3212836573

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.